Up next

Autoplay

Lyrica Patent Expiration Ushers In 9 Generic Competitors

2 Views • 08/20/25
Share
Side Effects
Side Effects
Subscribers
0

Register for our free featured webinar here: https://buff.ly/2YqNI64

Read more on this story here: https://buff.ly/2Kdzf8r

The moment that Pfizer has been dreading has finally arrived: the patent on its blockbuster nerve pain drug, Lyrica, has expired. The US Food and Drug Administration (FDA) authorized nine generic drug companies to make copycats of Lyrica (pregabalin), mere days after the expiration.

For more news stories, visit: https://bit.ly/2YQhQJh

Receive weekly news and webinar updates right in your inbox: https://xtalks.com/register/

Listen live and interact with featured speakers on our upcoming Life Science webinars: https://bit.ly/2YRzAV0

Show more
0 Comments sort Sort By

Up next

Autoplay